Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Drug Product
20 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Excipient Quality Assurance
Assuring Excipient Quality for Parenteral Products
Drug Product
Contract Manufacturing at the Leading Edge of Process Innovation
PAO-03-22-R250-10
FDA
FDA to Import Drugs from Other Countries
PAO-M07-18-NI-018
Acquistion
Siegfried Purchases the Drug Product Manufacturing Facility of Arena Pharmaceuticals GmbH in Zofingen
PR-M03-18-NI-058
Rights Acquisition
Nuvo Pharmaceuticals (Ireland) Limited Acquires U.S. Product Rights to Resultz® from Piedmont Pharmaceuticals LLC
PR-M01-18-NI-055
Product Pipeline
Moderna Announces 19 Development Candidates at JPM
PAO-M01-18-NI-021
Drug Development
Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds
PR-M01-18-NI-029
CFDA
China FDA Publishes Guidance for Priority Review
PAO-M01-18-NI-013
Hires
AMRI Names Michael Mulhern as Chief Executive Officer
PR-M01-18-NI-012
Biosimilars
Pfizer Receives FDA Approval for Remicade® Biosimilar
PAO-M12-17-NI-039
Drug Delivery
Needle-Free Injection Technology Advances to Phase II Trial
PAO-M12-17-NI-035
Investment
Transporters Targeting Cell’s Metabolic Gates Win Financing
PAO-M12-17-NI-037
Drug Delivery
Needle-Free Injection Technology Advances to Phase II Trial
PAO-M12-17-NI-035
FDA
NDA Submitted for Antimalarial Drug
PAO-M12-17-NI-034
Research
Tumor Killing Combo Wins Third U.S. Patent
PAO-M12-17-NI-033
Drug Development
Chinese Biopharma Receives Series A Financing
PAO-M12-17-NI-031
Strategic Partnership
BioVectra and Keryx Expand Strategic API Supply Relationship
PAO-M12-17-NI-030
Drug Development
New Generic for Kenalog-40 Approved
PAO-M12-17-NI-020
Diabetes
First “Follow-On” Insulin Product Approved
PAO-M12-17-NI-019
3D Printing
Aprecia and Cycle Team to Develop 3D-Printed Orphan Drugs
PAO-M12-17-NI-018
